Nanomedicine News

RSS

Nanotechnology Firm Liquidia Begins Phase 1 Clinical Trial of Influenza Vaccine

Liquidia Technologies, a privately held nanotechnology company developing particle-based vaccines and therapeutics, today announced the initiation of human dosing of its lead vaccine product candidate, LIQ-001, in a Phase 1 clinical trial.

From Liquidia Technologies, Inc. 6 Oct 2010

New Microfluidic Device to Test Anti-Cancer Drugs

A prototype device developed in Hong Kong will allow laboratory researchers to non-invasively test drugs for their ability to kill tumors by subjecting cancerous cells with different concentration gradients. The new d...

6 Oct 2010

Nanoparticles Deliver Combination of Chemotherapy Drugs Directly to Prostate-Cancer Cells.

In recent years, studies have shown that for many types of cancer, combination drug therapy is more effective than single drugs. However, it is usually difficult to get the right amount of each drug to the tumor.

5 Oct 2010

Georgia Tech and Emory University Receive Fund to Continue Nanotechnology Development

Georgia Tech and Emory University have received a five-year $14.6 million contract from the National Institutes of Health (NIH) to continue the development of nanotechnology and biomolecular engineering tools and methodologies for detecting and treating atherosclerosis.

5 Oct 2010

Researchers Develop New Nanomedicine Tool for Single Breath Analysis

Researchers at Stony Brook University have developed a new sensor nanotechnology that could revolutionize personalized medicine by making it possible to instantly detect and monitor disease by simply exhaling once into a handheld device.

4 Oct 2010

MIT-Mount Sinai Team Receives Funding for Nanotechnology Research

The National Heart, Lung, and Blood Institute is awarding an MIT-Mount Sinai Medical School team of researchers $16.4 million over the next five years to study new nanotechnology treatments for heart, lung and blood dise...

1 Oct 2010

CWRU Researcher to Receive Fund for Developing Nanotechnology-Based Platelets

A Case Western Reserve University researcher will receive a $2.3 million New Innovator Award today to further develop and broaden the uses of synthetic platelets and the technology that makes them work. Erin Lavik, as...

1 Oct 2010

Access Pharmaceuticals Files Patent for CobaCyte Nanoparticle Technology

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, ann...

1 Oct 2010

Using Michelson Diagnostics' Vivosight OCT to Evaluate Performance of New Microneedle Drug Delivery Technology

Michelson Diagnostics (MDL) the leading provider of clinical OCT imaging systems is pleased to report the use of its VivoSight OCT imaging system to evaluate the performance of a new microneedle drug delivery technology by researchers at Queen’s University Belfast led by Dr Ryan Donnelly.

30 Sep 2010

Mount Sinai Receives $16.5 Million Grant Through the Program of Excellence in Nanotechnology

Mount Sinai School of Medicine received a contract for almost $16.5 million from The National Institutes of Health (NIH) and the National Heart and Lung Institute (NHLBI) through the Program of Excellence in Nanotechnolo...

30 Sep 2010